It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Fluid overload (FO) with coincident acute kidney injury has been associated with increased mortality. However, it is unclear whether FO is an independent determinant of mortality for disease severity. We aimed to explore whether the development of fluid balance (FB) during the first 72 h of continuous renal replacement therapy (CRRT) is independently associated with hospital mortality. All patients admitted to a single centre ICU requiring CRRT for at least 24 h between years 2010–2019 were included. Extracted data included patient demographics and clinical parameters including daily cumulative fluid balance (FBcum), lactate, SOFA score and vasoactive requirement at the initiation and during the first 72 h of CRRT. 399 patients were included in the analysis. Hospital survivors had a significantly lower FBcum at CRRT initiation compared to non-survivors (median 1382 versus 3265 ml; p = 0.003). Hourly fluid balance per bodyweight (FBnet) was lower in survivors at 0–24, 24–48 and 48–72 h after initiation of CRRT (p < 0.008 for all comparisons). In the survival analysis (analyzed with counting process model) significant time-dependent explanatory variables for hospital mortality were FBnet (per ml/kg/h: HR: 1.319, 95% CI 1.038–1.677, p = 0.02), lactate (HR: 1.086, 95% CI 1.030–1.145, p = 0.002) and SOFA score (per ml/kg/h: HR: 1.084, 95% CI 1.025–1.146, p = 0.005) during the first 72 h of CRRT. Even after careful adjustment for repeated measures of disease severity, FBnet during the first 72 h of CRRT remains independently associated with hospital mortality, in critically ill patients with AKI.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Turku, Department of Anaesthesiology and Intensive Care, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371); Turku University Hospital, Perioperative Services, Intensive Care and Pain Medicine, Turku, Finland (GRID:grid.410552.7) (ISNI:0000 0004 0628 215X)
2 Turku University Hospital, Kidney Center, Turku, Finland (GRID:grid.410552.7) (ISNI:0000 0004 0628 215X)
3 University of Turku, Department of Biostatistics, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371)
4 University of Turku, Department of Anaesthesiology and Intensive Care, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371); Turku University Hospital, Perioperative Services, Intensive Care and Pain Medicine, Turku, Finland (GRID:grid.410552.7) (ISNI:0000 0004 0628 215X); Turku University Hospital, Kidney Center, Turku, Finland (GRID:grid.410552.7) (ISNI:0000 0004 0628 215X)